Clinical trial Recruiting at 1 site Interventional

How Different Levels of CPAP Deliver Oxygen to Preterm Babies

Official title: Oxygen Delivery in CPAP and Its Relationship With Regional Lung Ventilation in Preterm Infants

Run by University of Arkansas · NCT07674953 · Data updated 2026-11-12

This study tests how much oxygen actually reaches preterm infants when they receive nasal CPAP at different air pressures.

More Acute Respiratory Distress Syndrome trials

Quick facts

Study typeInterventional
SexAll
Enrollment10 (estimated)
SponsorUniversity of Arkansas
Academic / other
Locations2 sites (Little Rock, Arkansas and 1 other locations)
StatusRecruiting
StartedApril 15, 2026
Main results expectedDecember 2026
Study endsJune 2027
Registry record updatedJune 30, 2026
Trial IDNCT07674953 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Preterm infants (<35 weeks gestation) who are stable on nasal CPAP and using 22-40% supplemental oxygen.

Probably not a fit

Infants requiring invasive ventilation, with oxygen needs >40%, or with major congenital heart or lung anomalies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to measure the true oxygen delivery to preterm infants on nasal CPAP and how it may vary with different airway pressures. Researchers will collect measurements that are difficult to obtain in typical clinical care to see if the doctor-ordered oxygen matches what reaches the baby’s airway. The study focuses on infants born before 35 weeks who are stable on CPAP and using 22-40% supplemental oxygen, excluding those with higher oxygen needs or invasive ventilation. Findings could clarify whether adjustments in CPAP pressure change actual oxygen delivery and lung expansion. The study is conducted at the University of Arkansas for Medical Sciences in Little Rock, led by that institution.

Why it matters

Potential benefit: If successful, the study could help clinicians optimize oxygen delivery and CPAP settings for safer, more effective respiratory support.

How similar studies have gone: Previous work has explored CPAP effects on oxygen delivery, but direct measurements in this setting are limited, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Gestational age at birth must be less than 35 weeks of completed gestation as documented in the subject's initial history and physical
* The infant must be stable while receiving nasal CPAP at any pressure level at the time of study
* The infant must be receiving 22-40% at the time of the study

Exclusion Criteria:

* Oxygen requirements greater than 40% at time of enrollment
* currently receiving invasive ventilation or not requiring ventilatory support
* Major congenital anomalies of the heart and/or lungs

Where it's running

  • University of Arkansas for Medical Sciences
    Little Rock, Arkansas, United States
    Recruiting
  • University of Arkansas for Medical Sciences
    Little Rock, Arkansas, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.